Ursodeoxycholic Acid (UDCA) — Patient Information (UK)

Ursodeoxycholic acid (UDCA) is a medicine used to treat certain liver and bile-duct conditions. It belongs to a group of bile acids and works by changing the way bile behaves inside the body. This page explains what UDCA is, how it works, how it’s used in practice in the United Kingdom, and important safety information.

Please read the information below carefully. If anything is unclear—or if you are unsure whether UDCA is suitable for you—speak to a qualified healthcare professional.

Basic product information

How ursodeoxycholic acid works (mechanism of action)

Bile is a digestive fluid made by the liver and stored in the gallbladder. It helps break down fats and removes waste products from the body. In some liver and bile-duct conditions, bile flow is reduced or bile becomes harmful to liver cells.

UDCA works in several ways:

• Improves bile composition: UDCA replaces more toxic bile acids in the bile, making bile less damaging to cell membranes.
• Helps protect liver cells: It has a “cytoprotective” effect, reducing bile-related stress on liver cells.
• Enhances bile flow (choleretic effect): It may promote secretion and flow of bile.
• Supports immune and inflammatory pathways: In some cholestatic diseases, UDCA may influence inflammatory processes, though the exact mechanisms depend on the condition.

Pharmacokinetics (what the body does with UDCA)

Understanding how UDCA moves through the body can help you appreciate why regular dosing and ongoing follow-up are important.

• Absorption: UDCA is absorbed from the small intestine. After absorption, it enters the bloodstream and then returns to the liver.
• Distribution: Like other bile acids, UDCA is processed through the liver and incorporated into bile.
• Metabolism and excretion: UDCA undergoes further processing, including metabolism by gut bacteria (depending on the person’s microbiome), and is largely excreted via bile into the intestine.
• Elimination: UDCA is removed mainly through biliary pathways (bile), with a smaller contribution via other routes.
• Onset of effect: Some biochemical markers and symptoms may improve gradually. For some conditions, noticeable changes can take months.

What it’s used for (typical use and indications)

UDCA is used to manage specific diseases involving bile flow or bile composition. The exact suitability depends on your diagnosis and test results.

Common indications

• Primary biliary cholangitis (PBC): UDCA is a standard treatment to improve liver tests and slow disease progression in many patients.
• Dissolution of cholesterol gallstones: In selected patients with non-calcified, cholesterol stones in a functioning gallbladder, UDCA may be used to reduce or dissolve gallstones over time.
• Other cholestatic liver/bile-duct conditions: Use may depend on clinical judgment and local guidance.

If you have been advised to take UDCA, it is important to follow the plan tailored to your condition, including monitoring of liver function and, where relevant, imaging.

When and how to take UDCA (timing and practical routine)

The best timing depends on the formulation and your prescribed plan. Many UDCA regimens are taken once or twice daily, and some are scheduled around meals.

General timing guidance

• Take regularly: Aim for consistent dosing times every day.
• With or after food (often preferred): For many bile-acid medicines, taking with meals can help reduce stomach upset and may support bile-related processes.
• If the dose is split: Follow the schedule your healthcare professional provides (for example morning and evening).

If you forget a dose

• Take it when you remember unless it is close to the next dose.
• Do not double up to make up for a missed dose.
• If you miss several doses, ask a healthcare professional or pharmacist for advice.

How long you may need treatment

UDCA is often used long-term. For PBC, it may be continued for years. For gallstone dissolution, treatment can take many months, and not all stones respond.

Food interactions and dietary considerations

Food can affect how medicines are taken up by the body and how bile behaves. While UDCA is generally compatible with most foods, consider these points:

• Taking with meals: If you notice stomach discomfort, taking UDCA with food may be more comfortable.
• Maintain a balanced diet: If you have liver or gallbladder disease, your diet may already be tailored. Follow the advice you’ve been given (for example regarding fat intake).
• Weight changes and bile flow: Rapid weight loss or extreme dietary changes can affect gallstone risk and bile composition—seek advice if you plan significant changes.

Alcohol interactions

Alcohol may worsen liver health and can increase the risk of complications in people with liver disease. UDCA cannot “cancel out” alcohol-related harm to the liver.

• If you have liver disease: It is best to discuss alcohol use with a healthcare professional. Many people are advised to avoid or minimise alcohol.
• General safety: If you drink alcohol, do so cautiously and within the guidance provided for your health condition.

Interactions with other medicines (important)

UDCA can interact with certain medicines, especially those that bind bile acids or change bile function. Always provide your pharmacist with a full list of medicines and supplements you use.

Medicines that may reduce UDCA effectiveness

• Bile acid binding resins (for example, cholestyramine, colestipol): These can bind bile acids in the gut and may reduce UDCA absorption.
• Some antacids or gastrointestinal medicines may indirectly affect absorption depending on timing and ingredients.

Timing separation (general principle)

If you must take a bile-acid binder, your prescriber/pharmacist may recommend separating UDCA from the binder by several hours. Do not adjust timing without advice.

Other medicines and herbal products

• Immunosuppressants or liver-active medicines: People with liver conditions often take multiple treatments; monitoring is important.
• Herbal supplements: Some herbal products can affect liver enzymes. Tell your pharmacist about any supplements or “natural” products.

Safety profile (who should be careful)

UDCA is generally well tolerated, but side effects can occur. The safest approach is to use it as directed and to seek advice promptly if you develop concerning symptoms.

Common side effects

• Stomach or bowel changes: diarrhoea, loose stools, abdominal discomfort
• Nausea in some people

Serious but less common warning signs

Seek medical advice urgently if you develop:

• Severe or persistent diarrhoea or dehydration symptoms
• Signs of liver flare or worsening disease (for example, worsening jaundice, dark urine, marked fatigue, severe itching)
• Allergic reaction such as rash, swelling, or difficulty breathing

Who should avoid or use with extra caution

• Allergy to UDCA or any ingredient in the product
• Some types of gallstones are not suitable for dissolution (e.g., stones with calcium may not respond). Your clinician will assess via imaging.
• Significant liver/bile-duct obstruction may require different management.
• Children and adolescents: UDCA use depends on the specific condition, age, and specialist advice.

Pregnancy, breastfeeding, and fertility (UK general considerations)

If you are pregnant, planning a pregnancy, or breastfeeding, discuss UDCA with your healthcare professional. Liver-bile conditions may still require treatment, and the balance of risks and benefits will be considered for you.

Practical use tips (make treatment easier)

• Use a routine: Take UDCA at the same times daily to maintain steady levels.
• Stay hydrated: If you experience soft stools, maintaining fluid intake may help while you monitor side effects.
• Keep follow-up appointments: Regular blood tests (for example, liver function tests) are often needed to assess response.
• Monitor gallstone treatment if relevant: If UDCA is used to dissolve stones, imaging follow-up may be used to check progress.
• Read the pack: Different brands may have different strengths. Confirm your dose strength matches your plan.
• Tell healthcare professionals: Inform your dentist, pharmacist, and any specialists about UDCA use, especially before new treatments.

Dosing (general guidance)

UDCA dosing depends on the condition being treated, your weight, liver test results, and how you respond. The information below provides general reference points and should not replace your clinician’s instructions.

Common dosing principles

• Primary biliary cholangitis (PBC): Typical adult dosing is commonly calculated based on body weight (often in the range of ~13–15 mg/kg/day in clinical practice), usually given once or divided into two doses.
• Cholesterol gallstones dissolution: Dosing is often based on body weight and may be given once daily or divided doses; therapy can be prolonged.
• Adjustment and monitoring: Doses may be modified based on tolerance and blood test results.

Important: Always follow your prescribed dose and strength. If you’re unsure, check the label and ask a pharmacist.

What to expect during treatment

UDCA is aimed at improving bile flow and reducing bile-related liver injury. It does not typically work “overnight”.

• Biochemical improvement: Liver enzyme patterns may improve gradually.
• Symptom changes: Itching or fatigue may improve for some people, but this varies.
• Gallstone outcomes: Complete dissolution is not guaranteed; some stones do not respond and recurrence can occur after stopping.

Alternative options

Depending on your diagnosis, other treatments may be considered. Options may include:

• For PBC: UDCA remains the first-line therapy for many people; additional medicines may be considered if there is an incomplete response.
• For gallstones: management may include surgical approaches or other non-surgical strategies in selected cases.
• Supportive care: Symptom management for itch, nutritional support, and monitoring may be part of overall care.

Your clinician will select options based on test results, imaging, disease stage, and your personal circumstances.

UK market and legal context (what this means for you)

Medicines containing ursodeoxycholic acid are regulated in the United Kingdom under the Medicines and Healthcare products Regulatory Agency (MHRA) framework and associated medicines legislation. Availability and formulation depend on product licensing and supply.

In the UK, medicines may be supplied under different routes. Your ability to buy or receive UDCA through a pharmacy service depends on the product’s classification, local rules, and the relevant regulatory pathway for the particular medicine.

Recent guidance (high-level)

Clinical practice guidance for cholestatic liver diseases—including PBC—continues to emphasise:

• Using UDCA as a standard first-line option for appropriate patients.
• Monitoring response with blood tests over time to identify inadequate responders early.
• Escalating treatment when response is insufficient through specialist care, according to current evidence.

Local clinical guidelines and specialist pathways can vary. Your healthcare team will apply the latest approach for your condition.

Delivery and availability (UK pharmacy experience)

UDCA may be available in pharmacies and through authorised online pharmacy services in the UK, subject to availability, strength, and formulation. Typical availability depends on:

• Brand and strength (capsules/tablets; dosage per unit)
• Current supply levels
• Packaging size (number of capsules/tablets)

Delivery expectations

• Dispatch times: Often depend on stock availability.
• Cold chain: UDCA typically does not require refrigeration; follow the storage instructions on the pack.
• Tracking: Many services provide delivery updates and tracking where available.

Storage

• Store at the temperature stated on the pack.
• Keep out of reach and sight of children.
• Protect from moisture where indicated (follow label instructions).

FAQ — Frequently asked questions

1) How long does it take for UDCA to work?

It varies by condition. Some people see improvements in blood tests over months. If UDCA is used for gallstone dissolution, treatment commonly takes a prolonged period, and complete dissolution may not occur.

2) Can I drink alcohol while taking UDCA?

If you have a liver or bile-duct condition, it’s safest to avoid or minimise alcohol and follow advice from your healthcare professional. Alcohol can worsen liver health regardless of UDCA.

3) What should I do if I get diarrhoea?

Mild bowel changes can occur. If diarrhoea persists, becomes severe, or you feel unwell (or dehydrated), seek medical advice. Keep taking UDCA unless a healthcare professional tells you to stop.

4) Are there medicines I must separate from UDCA?

Medicines that bind bile acids (such as certain resins used for cholesterol/bile acid-related issues) may reduce UDCA absorption. Your pharmacist can advise on timing separation if you use any of these.

5) Can UDCA be taken with food?

Many people take UDCA with food or after meals. This can improve comfort and support a consistent routine. Follow your pack instructions and the plan you’ve been given.

6) What symptoms mean I should contact a doctor urgently?

Contact urgent medical care if you suspect an allergic reaction (rash, swelling, breathing difficulties), or if you notice signs of worsening liver disease such as significant jaundice, dark urine, severe itching, or severe unwellness.

7) Will UDCA dissolve all gallstones?

Not all gallstones dissolve. Response depends on stone type (often cholesterol), size, and whether the gallbladder is functioning properly, as assessed on imaging.

8) What if I’m switching brands or strengths?

Different brands may contain different strengths. Do not switch without confirming your total daily dose. Check the label and consult a pharmacist if you are unsure.

9) Can I take UDCA with herbal supplements?

Some supplements can affect the liver. It’s best to tell your pharmacist about all products you use, including herbal remedies and vitamins.

10) Do I need regular monitoring?

Often yes—particularly for PBC—where blood tests and follow-up help confirm response and guide ongoing care.

Summary

Ursodeoxycholic acid is a bile-acid medicine used for selected liver and gallstone conditions, most notably primary biliary cholangitis and certain cholesterol gallstones. It works by improving bile composition, supporting liver cell protection, and promoting bile flow. Treatment is usually taken regularly over months or years, with response assessed through follow-up and monitoring. If you notice persistent diarrhoea, allergic symptoms, or signs of worsening liver health, seek medical advice promptly.